OrbiMed’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-660,000
| Closed | -$22.9M | – | 154 |
|
|
2020
Q3 | $22.9M | Hold |
660,000
| – | – | 0.29% | 81 |
|
|
2020
Q2 | $21.6M | Hold |
660,000
| – | – | 0.3% | 73 |
|
|
2020
Q1 | $19.9M | Hold |
660,000
| – | – | 0.33% | 66 |
|
|
2019
Q4 | $19.1M | Hold |
660,000
| – | – | 0.27% | 69 |
|
|
2019
Q3 | $17.1M | Hold |
660,000
| – | – | 0.32% | 67 |
|
|
2019
Q2 | $16.8M | Hold |
660,000
| – | – | 0.26% | 74 |
|
|
2019
Q1 | $17.3M | Hold |
660,000
| – | – | 0.27% | 78 |
|
|
2018
Q4 | $15.2M | Hold |
660,000
| – | – | 0.28% | 75 |
|
|
2018
Q3 | $15.6M | Hold |
660,000
| – | – | 0.19% | 97 |
|
|
2018
Q2 | $15.2M | Hold |
660,000
| – | – | 0.18% | 100 |
|
|
2018
Q1 | $16.3M | Hold |
660,000
| – | – | 0.2% | 86 |
|
|
2017
Q4 | $17.7M | Hold |
660,000
| – | – | 0.22% | 83 |
|
|
2017
Q3 | $15.9M | Buy |
+660,000
| New | +$15.9M | 0.15% | 91 |
|